Edition:
United Kingdom

Profile: electroCore, Inc. (ECOR.OQ)

ECOR.OQ on NASDAQ Stock Exchange Global Select Market

1.39USD
17 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
55,697
52-wk High
$17.99
52-wk Low
$1.35

ElectroCore, Inc., formerly ElectroCore LLC, incorporated on September 13, 2005, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields.

The gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.

Company Address

electroCore, Inc.

150 Allen Rd Ste 201
Basking Ridge   NJ   07920-2977
P: +1973.2900097
F: +1973.2909171

Company Web Links